Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bazedoxifene in Women With Schizophrenia
NCT04113993Phase 4Recruiting
- Sponsor
- Alfred Health
- Start
- Oct 2019
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bazedoxifene in schizophrenia, schizophreniform disorder, schizoaffective disorder, sponsored by Alfred Health. Started Oct 2019; status: recruiting.
02
Drugs
bazedoxifene
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorder
Beyond the preview
Go deeper on NCT04113993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04113993.